Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
General Information of Drug (ID: DR2403) | ||||||
---|---|---|---|---|---|---|
Drug Name |
Fludarabine phosphate
|
|||||
Prodrug Info | Fludarabine phosphate is the prodrug of Fludarabine | |||||
Synonyms |
Fludarabine (phosphate); Fludarabine 5'-monophosphate; Fludarabine Phosphate (Fludara); Fludarabine monophosphate; Fludura; Gedeptin; Oforta; fludara; fludarabine phosphate; 1X9VK9O1SC; 2-Fluoro-9-(5-O-phosphono-beta-D-arabinofuranosyl)-9H-purin-6-amine; 2-Fluoro-ARA AMP; 2-Fluoroadenine arabinoside 5'-monophosphate; 75607-67-9; 9-beta-Arabinofuranosyl-2-fluoroadenine-5'-phosphate; 9-beta-D-Arab; 9-beta-D-Arabinofuranosyl-2-fluoroadenine 5'-monophosphate; C10H13FN5O7P; CHEBI:63599; FAMP; NSC 312887; NSC 328002; NSC-312887; UNII-1X9VK9O1SC
|
|||||
Indication | Chronic lymphocytic leukaemia [ICD11: 2A82] | Approved | [1] | |||
Structure | ||||||
3D MOL | 2D MOL | |||||
Pharmaceutical Properties | Molecular Weight | 365.21 | Topological Polar Surface Area | 186 | ||
Heavy Atom Count | 24 | Rotatable Bond Count | 4 | |||
Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 12 | |||
Cross-matching ID |
|
|||||
The Metabolic Roadmap of This Drug | |||||
---|---|---|---|---|---|
The Full List of Drug Metabolites (DM) of This Drug | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
The Full List of Metabolic Reaction (MR) of This Drug | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||||||||
Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.